Articles by Disease (Non-melanoma Skin Cancer)

Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?

Journal: Current Pharmaceutical Design
Volume: 12
Page: 3817-3825
Author(s): M. Cemazar, M. Golzio, G. Sersa, MP. Rols and J. Teissie

IgE, Allergic Diseases, and Omalizumab

Journal: Current Pharmaceutical Design
Volume: 12
Page: 3929-3944
Author(s): L. M. DuBuske

Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents

Journal: Current Pharmaceutical Design
Volume: 12
Page: 3411-3421
Author(s): Y. Matsuzaki and A Honda

Selected Players in the Inflammation Cascade and Drugs That Target These Inflammation Genes Against Metastasis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6
Page: 461-468
Author(s): Shanavas Alikunju and Sivaram Pillarisetti

Sorafenib (BAY 43-9006): Review of Clinical Development

Journal: Current Clinical Pharmacology
Volume: 1
Page: 223-228
Author(s): Raymond Ng and Eric X. Chen

The Relevance of Microdialysis for Clinical Oncology

Journal: Current Clinical Pharmacology
Volume: 1
Page: 255-263
Author(s): Jos J. E.M.Kitzen, Jaap Verweij, Erik A. C.Wiemer and Walter J. Loos

Cytotoxic Potential of Phenothiazines

Journal: Current Drug Targets
Volume: 7
Page: 1055-1066
Author(s): Noboru Motohashi, Masami Kawase, Kazue Satoh and Hiroshi Sakagami

STAT3: A Molecular Target for Cancer Whose Time Has Come

Journal: Current Signal Transduction Therapy
Volume: 1
Page: 239-253
Author(s): Beverly E. Barton

Carotenoids as Modulators of Intracellular Signaling Pathways

Journal: Current Signal Transduction Therapy
Volume: 1
Page: 325-335
Author(s): Paola Palozza, Simona Serini and Gabriella Calviello

Current Status of Clinical Trials for Glioblastoma

Journal: Reviews on Recent Clinical Trials
Volume: 1
Page: 265-281
Author(s): Michael L. Salgaller and Linda M. Liau